Descriptive Statistics of Related Variables, <i>N</i>=187, China, 2017–2019. حسب Wenbin Wang (404991)

الموضوعات:

Descriptive Statistics of Related Variables, <i>N</i>=777, China, 2017–2019. حسب Wenbin Wang (404991)

الموضوعات:

Blood Pressure and LDL-C During Follow-up. حسب Karl Ingard (22582091)

"…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…"

Baseline Characteristics of Included Patients. حسب Karl Ingard (22582091)

"…The risk of cardiovascular death was significantly decreased (HR 0.64, 95% CI 0.41–0.998, <i>P</i> = 0.049) and the risk of fracture non-significantly increased (HR 1.47, 95% CI 0.95–2.27, <i>P</i> = 0.08) in the intervention group compared to the control group.…"

The Laboratory Animal Flow Diagram. حسب Xueqin lu (22250795)

الموضوعات:

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). حسب Xueqin lu (22250795)

الموضوعات:

General procedure for the synthesis of B. حسب Xueqin lu (22250795)

الموضوعات:

The trends of gene expression in the metabolism of triglycerides in liver tissue. حسب Xueqin lu (22250795)

الموضوعات:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. حسب Xueqin lu (22250795)

الموضوعات:

¹H NMR spectra for kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

Kylo-0603’s EC50 & tissue levels. حسب Xueqin lu (22250795)

الموضوعات:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. حسب Xueqin lu (22250795)

الموضوعات:

The Fibrosis scoring by Sirius Red staining and SHG/TPEF. حسب Xueqin lu (22250795)

الموضوعات:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. حسب Xueqin lu (22250795)

الموضوعات:

Plasma cholesterol and LDL-C levels. حسب Xueqin lu (22250795)

الموضوعات:

¹³C NMR spectra for Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

General procedure for the synthesis of A and A-c1. حسب Xueqin lu (22250795)

الموضوعات:

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... حسب Xueqin lu (22250795)

الموضوعات:

DIO Mice Liver Staining. حسب Xueqin lu (22250795)

الموضوعات:

NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). حسب Xueqin lu (22250795)

الموضوعات: